Injection of LRP5 and LRP6 antibodies suppressed activation of the WNT pathway and decreased ECM formation in DN animal models, suggesting that WNT/β-catenin signaling might be involved in tubular-interstitial fibrosis in DN [10]. Here, LRP5 is linked to liver dysplastic nodule.